SANDY SUBLETT: Open Payments
NPI 1932202728 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,267 in 55 payments from 19 companies in 2025. Trend: 2023 $702 · 2024 $1,025 · 2025 $1,267
Food & beverage: $1,267
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $149 |
| Terumo Medical Corporation | 1 | $126 |
| Actelion Pharmaceuticals US, Inc. | 6 | $125 |
| Merck Sharp & Dohme LLC | 6 | $112 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $109 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $76 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| PFIZER INC. | 3 | $68 |
| Alnylam Pharmaceuticals Inc. | 2 | $67 |
| United Therapeutics Corporation | 2 | $65 |
Products named: Wegovy, AZUR CX DETACHABLE, Kerendia, UPTRAVI, VERQUVO, JARDIANCE, FARXIGA, AMVUTTRA.
Industry payments across AL — which companies pay providers there.
